CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Dr Morag Park
Robert L. Noble Prize, 2017 recipient
Dr Park has also expanded our understanding of the non-cancerous supportive cells that surround tumours – the tumour microenvironment. For example, she has described how patterns of gene activity in the tumour’s supportive cells can predict how women with breast cancer will fare in the clinic. This research also opened a new avenue for cancer therapy development.
As a top scientific leader in Canada, Dr Park served as the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Cancer Research (ICR) from 2008–2013. In this role, she was instrumental in establishing partnerships between Canadian and international cancer research organizations to coordinate research efforts.
Dr Park is regarded as one of the most influential breast cancer researchers worldwide. Her work has deepened our understanding of cancer, and she has guided our research community to make the most impact on cancer in Canada and beyond.